PharmEasy Secures New Debt to Settle Goldman Sachs Loan Amidst Steep Valuation Drop
PharmEasy raises Rs 1,700 crore in debt funding, continuing reliance on high-cost borrowing amid losses.
PharmEasy raises Rs 1,700 crore in debt funding, continuing reliance on high-cost borrowing amid losses.
API Holdings’ PharmEasy reported flat revenue but cut losses by 38%, improving finance and depreciation costs.
Siddharth Shah is stepping down as CEO of API Holdings, transitioning to Vice Chairman on Aug 27, 2025.
All Home aims to streamline home interiors with a one-stop solution for various design products.